October Pharma logs 20.1% YoY higher profit in 9 months: Egypt

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances

Staff Writer, Arab Finance

November 13, 2023

PHOTO

October Pharma (OCPH) has reported a 20.09% year-on-year (YoY) increase in net profit after tax of EGP 130.739 million during the first nine months of 2023, from EGP 108.864 million in the same period a year earlier, according to the financial statement filed to the Egyptian Exchange (EGX) on November 12th.

Net sales reached EGP 704.372 million in the January-September period of 2023, up from EGP 540.86 million in the same period of 2022.

October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.